CEL-SCI Corporation (CVM) News
Follow CEL-SCI Corporation (CVM) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
CEL-SCI Corporation (NYSE American: CVM) today announced that the Company’s Chief Scientific Officer, Dr. Eyal Talor, has been invited to deliver a keynote presentation at the 6th World Congress on Otology, Rhinology and
GEOPOLITICS | Sep 15, 2026, 12:37 PM UTC
L
CEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study
CEL-SCI Corporation...
EQUITY | Jul 13, 2026, 12:10 PM UTC
M
CVM Signs Agreement
CVM CEL-SCI and Saudi Amarox sign strategic agreement at BIO 2026 to advance U.S.-Saudi cooperation in cancer care
EQUITY | Jun 24, 2026, 12:00 PM UTC